The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.25
Bid: 35.00
Ask: 35.50
Change: 0.00 (0.00%)
Spread: 0.50 (1.429%)
Open: 35.25
High: 35.25
Low: 35.25
Prev. Close: 35.25
CREO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Call Option Agreement

21 Nov 2008 09:24

RNS Number : 6520I
China Real Estate Opportunities Ltd
21 November 2008
 

China Real Estate Opportunities Limited

 

CREO ANNOUNCES CALL OPTION IN RREEF CHINA COMMERICIAL TRUST

 

21 November 2008, Hong Kong - China Real Estate Opportunities Limited ("CREO" or the "Company"), an AIM listed property company with an established investment and development portfolio in China today announced that it had entered into a call option agreement to acquire a 25.65% stake or 119,043,500 units in RREEF China Commercial Trust ("RREEF CCT"), a Hong Kong-listed Real Estate Investment Trust ("REIT"), to be exercised on 12 January 2009 at a cost of HKD 387 million (£33.6 million). 

RREEF CCT listed on the Hong Kong Stock Exchange on 22 June 2007 and currently owns an international grade A office and retail complex in the Chaoyang District of Beijing. The property, Beijing Gateway Plaza, is a strongly performing commercial real estate asset of approximately 130,000 square metres, with occupancy of over 95%, and is entirely consistent with CREO's long-term investment and operating philosophy.

RREEF CCT is managed by RREEF China Reit Management Limited, which is owned by RREEF Alternative Investments through Deutsche Bank Asia Pacific.

As at June 2008, RREEF CCT had a net asset value (NAV) of HKD6.04 per share, whilst the individual asset had a gross property value of HKD8.56 per share (HKD3.99 billion, £347.0 million). An interim dividend of HKD18.63 cents per share was paid in June 2008. Based on the share price of HKD1.880 on 20 November 2008, RREEF CCT had a market capitalisation of HKD873 million (£75.9 million). 

CREO has secured the call option at HKD3.25 per share representing a 46% discount to NAV and 62% discount to gross property valueBased on the interim dividend outlined in the June 2008 interim accounts the exercise price of the call option of HKD3.25 equates to a dividend yield of 11.5% per annum.

Mr. Ray Horney, Chairman of China Real Estate Opportunities Limited said, "This transaction reinforces CREO's ongoing commitment to its core business and exhibits its capacity to identify strategic investments that maintain its position as one of the leading foreign investors in China's commercial real estate market and that are accretive to its existing investments".

-- Ends --

About CREO

CREO was listed on the AIM market in London on 11th July 2007 under ticker symbol CREO, having successfully raised £259 million. Harnessing the intimate local market knowledge and key relationships that Treasury Holdings has been able to develop through its presence in China since 2002, CREO's principal objective is to maximise capital growth from a portfolio of properties in China. The projects will all incorporate high quality design, specifications, and finishes synonymous with Treasury Holdings.

CREO, with an exclusive focus on the China real estate market currently owns seven high-quality, strategically located properties in ShanghaiBeijing, and Qingdao. The company's main focus is in the commercial real estate sector, with income-producing properties currently representing 75% of the total portfolio.

www.china-reo.com

www.treasuryholdings.com

For further information, please contact:

CREO

Ray Horney, Chairman

Tel: + 44 (0)1273 775225

Sarah Moriarty, Investor Relations 

Tel: +353 1 6189455

Treasury Holdings China 

Richard David, Managing Director

Tel: (+86) 21 6282 5000 

Davy

Des Carville

Tel: +353 1 679 6363

Media Enquiries:

Bankside Consultants

Simon Rothschild, Oliver Winters

Tel: + 44 (0)207 367 8888

Murray Consultants

Ed Micheau

Tel: + 3531 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGREAPFFADAPFEE
Date   Source Headline
7th May 20207:00 amRNSFinal Results
23rd Mar 20207:00 amRNSFDA Clearance for HS1 Haemostasis Device
20th Mar 20207:00 amRNSTrading update – COVID-19 impact
4th Mar 20205:00 pmRNSExercise of Options
24th Feb 20203:49 pmRNSHolding(s) in Company
19th Feb 20207:00 amRNSLTIP Awards and Issue of Equity
11th Feb 20207:00 amRNSVideo abstracts re. Speedboat procedures in India
7th Feb 202011:50 amRNSExercise of Options
6th Feb 20207:00 amRNSGrowth & Innovation Forum 2020
3rd Feb 20207:00 amRNSAppointment of NED
30th Jan 20207:00 amRNSTrading update
30th Dec 20193:17 pmRNSHolding(s) in Company
27th Dec 20195:00 pmRNSHolding(s) in Company
24th Dec 20198:01 amRNSDirector/PDMR Shareholding
23rd Dec 201911:15 amRNSResult of General Meeting and Total Voting Rights
23rd Dec 20197:00 amRNSResult of Open Offer
4th Dec 20197:00 amRNSRe. Placing, Open Offer, and Posting of Circular
2nd Dec 20197:00 amRNSFundraising and Launch of Accelerated Book Build
20th Nov 20197:00 amRNSFirst in-human cases in India
22nd Oct 20197:00 amRNSCommercial Launch of Speedboat at UEG Week
17th Oct 20197:00 amRNSUK Endoscopy Training Course
30th Sep 20197:00 amRNSHalf-year Report
26th Sep 20197:00 amRNSFramework Distribution Agreement for India
23rd Sep 20192:16 pmRNSNotice of Results
10th Sep 20197:00 amRNSUS Clinical Education Programme enters Phase II
7th Aug 20191:57 pmRNSDirector/PDMR Shareholding
5th Jul 20197:00 amRNSInstitute of Physics Award
25th Jun 20197:00 amRNSFirst commercial orders for Speedboat
6th Jun 20191:23 pmRNSResult of AGM
13th May 201910:50 amRNSAnnual Reports & Accounts & Notice of AGM
10th May 20197:00 amRNSMello 2019
24th Apr 20197:00 amRNSNew video abstract featuring Speedboat published
5th Apr 20197:00 amRNSFinal Results
28th Mar 20197:00 amRNSUpdate on US Clinical Education Programme
21st Mar 20192:34 pmRNSExercise of Options
21st Mar 20197:00 amRNSNotice of results and investor briefing
18th Mar 20197:00 amRNSCreo founder in Sunday Times 100 UK entrepreneurs
14th Mar 20195:17 pmRNSHolding(s) in Company
12th Mar 20199:19 amRNSSpeedboat in BSG Endoscopy best video abstract
6th Mar 201912:58 pmRNSExercise of Options
11th Feb 20197:00 amRNSDistribution agreement for France, Germany, Italy
24th Jan 201911:17 amRNSGrowth & Innovation Forum 2019
16th Jan 20197:00 amRNSFirst use of Speedboat in the US
17th Dec 20184:28 pmRNSExercise of Options
3rd Dec 20187:00 amRNSFirst placement and use of Speedboat in Europe
23rd Nov 201810:43 amRNSDirector/PDMR Shareholding
19th Nov 20181:30 pmRNSExercise of Options
22nd Oct 20182:52 pmRNSHolding(s) in Company
19th Oct 20187:00 amRNSUK Endoscopy Training Course
17th Oct 20187:00 amRNSSpain & Benelux Framework Distribution Agreements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.